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Background: The delta neutrophil index (DNI) is a useful marker for diagnosing and predicting the prognosis of sepsis. The purpose 
of this study was to investigate the usefulness of DNI as a prognostic marker in patients within the pediatric intensive care unit (PICU), 
as well as its association with other prognostic factors.
Methods: A total of 516 children admitted to Severance Children’s Hospital PICU from December 2009 to February 2015 were ana-
lyzed. DNI was measured on the day of PICU admission. Mortality was defined as death within 28 days following PICU admission.
Results: The median value of DNI was 1.2% (interquartile range [IQR] 0-4.3%) in the survivor group and 9.5% (IQR 2.3-20.8%) in the 
non-survivor group, and the difference was statistically significant (p < 0.001). DNI was significantly positively correlated with ICU 
scores such as Pediatric Index of Mortality 3 and Pediatric Risk of Mortality III, as well as with C-reactive protein and lactate levels. The 
area under the receiver operating characteristic curve of DNI for mortality was 0.748 (95% CI: 0.687-0.808) and the cut-off value was 
4.95%.
Conclusions: The initial DNI level can be considered a useful indicator for predicting prognosis in PICU patients.
Key Words: child; intensive care unit; mortality; prognostic factor.
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Introduction
The outcome of critically ill children recovering from life-threatening diseases in intensive care situations has im-
proved owing to advancing diagnostic and therapeutic methods.[1] Clinicians recognized the importance of identify-
ing patients with the highest risk of mortality among those admitted to the pediatric intensive care unit (PICU), and of 
proper monitoring and appropriate intervention and treatment. They also recognized the need to observe and treat high-
risk patients more aggressively, using appropriate indicators to predict mortality.
Many studies of mortality predictors in PICU patients have been performed, and ICU scoring systems such as the pe-
diatric risk of mortality III (PRISM-III), pediatric index 
of mortality 2 (PIM2), PIM3, and pediatric logistic organ 
dysfunction have been validated and are being used in 
clinical practice.[2-5] In addition, studies on the associa-
tion between mortality and laboratory biomarkers such as 
C-reactive protein (CRP), platelet count, procalcitonin, 
transthyretin and eosinophil count in adult ICU patients 
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have also been performed.[6-11]
The delta neutrophil index (DNI) is a parameter mea-
sured by a specific type of automated blood cell analyzer, 
the ADVIA2120 Hematology System and reflects circu-
lating immature granulocytes (IGs).[12] The ADVIA 2120 
Hematology System is a flow cytometry-based hemato-
logic analyzer comprised of two independent white blood 
cell (WBC) analysis methods (peroxidase and lobularity/
nuclear density channels).[13,14] The difference between 
the leukocyte differentials assayed in the peroxidase chan-
nel and those measured in the nuclear lobularity channel is 
defined as the DNI.[12]
In a previous study in adult patients with suspected sep-
sis, the DNI was helpful in evaluating clinical severity.
[12] In another study, the DNI elevated in patients with 
sepsis or septic shock and overt disseminated intravascu-
lar coagulation (DIC) have been proposed as a marker of 
disease severity in patients with sepsis.[15] Meanwhile, 
DNI was suggested as a marker to discriminate adult 
onset Still’s disease from sepsis.[16] IGs are also an in-
dicator of a left shift occurring due to infection, and are 
a meaningful discriminator the presence of sepsis. It was 
also reported to be a predictor of infection and positive 
blood cultures.[17,18] In a study of infants, an increase 
in IG was associated with positive blood cultures.[19]
There have been some studies on the associations be-
tween DNI/IGs and the severity of sepsis, but no research 
has been conducted on the relationship between these 
parameters and survival in critical ill children. Therefore, 
the purpose of this study was to investigate the useful-
ness of DNI in pediatric patients admitted to the PICU 
as a predictor of survival and prognosis, in addition to its 
association with other known prognostic factors.
Materials and Methods
1) Patients and variables
Children under the age of 18 who were admitted to the 
PICU at Severance Children’s Hospital, Seoul, Korea be-
tween December 2009 and February 2015 were included 
in this study. Patients originated from the emergency 
room or the general ward. The medical records of 516 
children were analyzed retrospectively. Patients who died 
or were transferred to the general ward within 24 h after 
ICU admission were excluded. The collected data includ-
ed patient age, sex, ICU admission diagnosis, absence 
or presence of mechanical ventilation within 24 h after 
ICU admission, length of ICU stay, blood and sputum 
culture results, in addition to complete blood cell (CBC) 
count, coagulation parameters, erythrocyte sedimentation 
rate (ESR), and CRP at admission. Additionally, PRISM 
III,[20] PIM2,[21] and PIM3[22] were calculated to de-
fine the severity of a patient’s condition within the first 
24 h of ICU admission. Survival or death was defined as 
the 28-day fatality following ICU admission. DNI values 
were recorded on the day of ICU admission. Patients 
were divided into the following three groups based on 
the initial DNI level: no increase in DNI (< 5%), low 
DNI (5-20%), and intermediate-to-high DNI (> 20%).
[12] This study was approved by the Institutional Review 
Board of Severance Hospital (protocol no. 4-2015-1212).
2) DNI measurement
Blood samples for DNI measurement were obtained by 
venipuncture or indwelling catheter. They were drawn 
into ethylene diamine tetra acetic acid-treated tubes 
and analyzed within 24 h of blood sampling. DNI was 
measured using an ADVIA2120 Hematology System 
(Siemens Healthcare Diagnostics, Forchheim, Germany, 
2010).[13,14] After lysis of red blood cells (RBC), a 
tungsten-halogen-based optical system of the peroxidase 
channel measures the forward light scatter (cell size) and 
absorbance (stain intensity) to count and distinguish lym-
phocytes, monocytes, neutrophils, and eosinophils based 
on size and peroxidase content. The laser diode-based 
optical system of the lobularity/nuclear density channel 
uses an acidic reagent to lyse RBCs and platelets and 
strips the cytoplasmic membrane from all of the WBCs 
except basophils. Cells are counted and classified accord-
ing to size (basophils are recognized as the largest cells 
because they have a cytoplasmic membrane), lobularity 
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and nuclear density. This channel provides valuable in-
formation about the degree of maturity of each WBC’s 
nucleus by measuring its lobularity and density, in ad-
dition to reporting the WBC count and basophil count. 
The DNI can therefore be calculated using the follow-
ing formula: DNI = (the neutrophil subfraction and the 
eosinophil subfraction measured in the myeloperoxidase 
[MPO] channel by the cytochemical MPO reaction) – (the 
polymorphonuclear neutrophil [PMN] subfraction mea-
sured in the nuclear lobularity channel by the reflected 
light beam).[15]
3) Statistical analysis
Categorical variables are represented as numeric values 
(percentages) and continuous variables as median values 
(interquartile ranges [IQRs]). Groups were compared by 
the chi-square test or Fisher’s exact test for categorical 
variables, and the Mann–Whitney U test, as appropriate. 
The associations between DNI and the ICU scoring sys-
tem values and other laboratory parameters were exam-
ined using Spearman’s method.
Receiver operating characteristic (ROC) curves and the 
respective area under the curve (AUC) of DNI at ICU ad-
mission for predicting mortality were calculated.[23] The 
Youden[24] method was used to select an “optimal” DNI 
level for predicting mortality. Patients were stratified into 
two groups according to this optimal level for analyses. 
Kaplan-Meier curves were constructed using these strata 
and compared using log-rank testing. Statistical analyses 
were performed using SPSS 20 (SPSS, Inc., Chicago, IL, 
USA) and R software (R version 3.2.4). P-values < 0.05 
were considered statistically significant for all analyses.
Results
1) Characteristics of the study population
A total of 516 children were analyzed in this study. 
Among them, 422 patients survived and 94 died (mor-
tality rate of 18.2%). The reasons for ICU admission 
included respiratory disease, such as pneumonia, bron-
chiolitis obliterans or laryngomalacia, in 270 patients 
(52.3%); neurological problem, such as epilepsy, hypoxic 
ischemic encepharopathy or encephalitis, in 91 patients 
(17.6%); nephrologic problem, such as renal failure or 
hemolytic uremic syndrome, in 24 patients (4.7%); post-
operative care, in 39 patients (7.6%); hemato-oncologic 
problem, such as tumor lysis syndrome or neutropenic 
fever in patients having chemotherapy, in 36 patients 
(7.0%); gastrointestinal problem, such as gastrointestinal 
bleeding or hepatic failure, in 30 patients (5.8%); meta-
bolic disorder in 10 patients (1.9%) and other problem in 
30 patients (5.8%).
Baseline characteristics of the study population, shown 
in Table 1, were compared between the survivor and non-
survivor groups. The DNI was significantly higher in the 
non-survivor group (median [IQR] 9.5 [2.3-20.8]) than in 
the survivor group (1.2 [0-4.3]) (p < 0.001). The platelet 
count was lower (p < 0.001) and CRP was higher (p < 
0.001) in the non-survivor group. Scores on three differ-
ent ICU scoring systems (PRISM III, PIM2, and PIM3) 
that evaluate the severity of the patient’s condition were 
all significantly higher in the non-survivor group. Pro-
thrombin time (PT) (p < 0.001), international normalized 
ratio (p < 0.001), and D-dimer levels (p = 0.001) were 
significantly higher in the non-survivor group. No signif-
icant differences were observed in sex, positive sputum 
culture rates, ESR, and or antithrombin III (ATIII) levels 
between the survival and mortality groups.
2)  DNI level in the immunocompromised and immuno-
competent patients
Among 516 patients, 72 children were the immunocom-
promised patients who were defined as having current 
chemotherapy treatment, immunosuppressive therapy, or 
having undergone hematopoietic stem cell or solid organ 
transplantation. The DNI was significantly higher in the 
immunocompromised patients (median [IQR] 4.7 (0.3-
30.6)] than in the immunocompetent patients (1.6 [0-5.3]) 
(p = 0.001). In the immunocompromised patients, 32 pa-
tients (44.4%) were classified as the non-survival group 
and the DNI was higher in the non-survivor group (me-
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dian [IQR] 15.3 [3.3-28.2]) than in the survivor group (1.9 
[0-6.8]) (p = 0.001).
3)  Comparisons of patients according to DNI level at 
ICU admission and the relationship between DNI and 
other parameters
Table 2 compares characteristics among the three pa-
tient subgroups based on DNI level at ICU admission: 
DNI < 5% (n = 366), DNI 5-20% (n = 111), and DNI > 
20% (n = 39). As DNI increased, the proportion of survi-
vors declined (p < 0.001). The three ICU scores also in-
creased parallel with increasing DNI (p = 0.001). Platelet 
levels were lowest in the high DNI group (p = 0.005). 
DNI was significantly positively correlated with the three 
ICU scores (r = 0.377, p < 0.001 for PRISM III; r = 0.274, 
p < 0.001 for PIM2; and r = 0.317, p < 0.001 for PIM3) 
Table 1. Characteristics of the study population
Survivor (n = 422) Non-survivor (n = 94) p-value
Clinical characteristics
  Age (years) 2.5 (0.9-7.1) 4.6 (1.6-10.2) 0.006
  Male sex 248 (58.8) 60 (63.8) 0.416
  Positive blood culture 18 (4.3) 11 (12.5) 0.009
Positive sputum culture 64 (16.7) 10 (12.5) 0.405
Mechanical ventilation (1 h) 377 (89.3) 90 (96.8) 0.028
Mechanical ventilation (24 h) 298 (70.6) 81 (87.1) 0.001
  Length of ICU stay (days) 9.5 (5-20) 6.0 (2-15) 0.001
ICU scoring systems
  PRISM III 5 (2-10) 19 (10-28) < 0.001
  PIM2 (%) 9.6 (5.1-26.9) 45.7 (22.2-81.3) < 0.001
  PIM3 (%) 6.7 (3.7-15.4) 32.4 (16.8-82.5) < 0.001
Hematologic variables
  DNI (%) 1.2 (0-4.3) 9.5 (2.3-20.8) < 0.001
  WBC (103/μL) 11160 (6913-17083) 8355 (3348-17968) 0.001
  Hb (g/dL) 10.5 ± 1.9 10.1 ± 2.8 0.140
  ANC (/μL) 7730 (4140-12735) 5415 (2119-12633) 0.019
  Platelets (103/μL) 295.5 (178.5-428.3) 136.0 (60.0-266.3) < 0.001
  ESR (mm/hr) 12.0 (2-31) 4.0 (2-31) 0.173
  CRP (mg/L) 8.0 (1.8-38.0) 25.0 (8.9-118.9) < 0.001
Coagulation parameters
  PT (sec) 12.5 (11.4-14.0) 15.2 (12.2-20.8) < 0.001
  INR 1.1 (1.0-1.2) 1.4 (1.1-1.8) < 0.001
  aPTT (sec) 32.4 (28.3-38.0) 45.1 (30.4-79.5) < 0.001
  Fibrinogen (mg/dL) 258 (181-347) 218 (134-320) 0.096
  D-dimer (ng/mL) 636 (305-1328) 1111 (453-3663) 0.001
  ATIII (%) 88 (67-106) 72 (56-104) 0.109
Lactate 1.4 (0.9-2.4) 5.2 (1.9-14.3) < 0.001
Data are presented as the median (interquartile range) or number of patients (percentage).
p-values are from the chi-square test or Mann–Whitney U test used to compare differences between the survivor and non-survivor groups.
ICU: intensive care unit; PRISM: pediatric risk of mortality; PIM: pediatric index of mortality; DNI: delta neutrophil index; WBC: white blood cells; Hb: hemoglobin; ANC: 
absolute neutrophil count; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; PT: prothrombin time; INR: international normalized ratio; aPTT: activated partial 
thromboplastin time; ATIII: antithrombin III.
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as well as lactate (r = 0.264, p < 0.001) and CRP (r = 
0.344, p < 0.001). 
4)  ROC curve of DNI and comparison of survival curves 
according to DNI cut-off level
Figure 1 shows the ROC curve of DNI for predicting 
mortality. The AUC was 0.748 (95% confidence interval 
0.687-0.808; p = 0.001) and the optimal cut-off value 
was 4.95%. Sensitivity and specificity were 63.8% and 
78.7%, respectively. With a cut-off value of 5.0%, sensi-
tivity and specificity were 63.4% and 78.7%, respective-
ly. The patients were divided into two groups according 
to their initial DNI levels; DNI ≥ 5.0% (n = 150) and < 
5.0% (n = 366). Kaplan–Meier curves showed the prob-
ability of survival in each group (Fig. 2). Patients with 
lower DNI levels had significantly longer survival time 
in the log-rank test (p < 0.001).\
Discussion
We retrospectively analyzed the medical records of 516 
children admitted to the PICU during a period of 5 years. 
At ICU admission, the median DNI was significantly 
Table 2. Comparisons of study patients according to DNI level at ICU admission
No increase in DNI (< 5)
(n = 366)
Low DNI (5-20)
(n = 111)
Intermediate-high DNI ( > 20)
(n = 39)
p-value
Clinical characteristics
  Age (years) 2.39 (0.98-6.61) 3.43 (1.38-7.9) 7.48 (3.02-10.56) 0.001
  Male sex 212 (57.9) 68 (61.3) 28 (71.8) 0.608
  Survivors 317 (86.6) 67 (60.4) 27 (69.2) < 0.001
  Mechanical ventilation 246 (67.2) 99 (90.0) 34 (87.2) < 0.001
ICU scoring systems
  PRISM III 5 (1.0-10.0) 10.0 (6.0-18.0) 20.0 (10.0-31.0) < 0.001
  PIM2 10.2 (5.1-27.6) 21.2 (7.5-45.1) 48.1 (8.7-91.7) < 0.001
  PIM3 7.1 (3.6-15.9) 12.8 (5.4-29.3) 43.8 (6.8-93.2) < 0.001
Hematologic variables
  WBC (103/μL) 10.78 (6.58-15.68) 13.29 (6.84-23.86) 6.68 (2.46-14.9) 0.003
  ANC (/μL) 7,441 (3,890-11,880) 9,740 (4,980-19,340) 4,170 (1,294-9,804) 0.005
  Hb (g/dL) 10.4 (9.3-11.6) 10.6 (8.9-12.0) 9.9 (7.8-11.3) 0.213
  Platelets (103/μL) 295 (181-437) 223 (92-380) 132 (55-251) < 0.001
  ESR (mm/h) 12.0 (2.0-31.0) 9.5 (2.0-34.2) 5.5 (2.0-35.8) 0.668
  CRP (mg/L) 7.4 (1.7-31.2) 19.2 (4.9-71.3) 98.5 (16.1-167.6) < 0.001
Coagulation parameters
  PT (sec) 12.5 (11.4-14.0) 13.0 (11.6-16.2) 16.3 (13.5-22.6) < 0.001
  INR 1.10 (1.00-1.21) 1.13 (1.02-1.42) 1.45 (1.23-1.98) < 0.001
  aPTT (sec) 31.7 (28.1-37.9) 35.7 (29.7-52.3) 45.8 (32.7-61.4) < 0.001
  D-dimer (ng/mL) 539.0 (284-1194) 946.5 (543-2718) 1444.5 (449-7603) < 0.001
  ATIII (%0 88.5 (67.0-107.0) 79.0 (60.5-104.8) 69.0 (58.3-82.0) 0.013
Lactate (mmol/L) 1.4 (0.9-2.4) 2.1 (1.2-4.9) 4.6 (1.6-14.0) < 0.001
Data are presented as the median (interquartile range) or number of patients (percentage).
p-values are from the chi-square test or Kruskal–Wallis test used to compare differences between DNI groups.
ICU: intensive care unit, PRISM: pediatric risk of mortality, PIM: pediatric index of mortality, DNI: delta neutrophil, WBC: white blood cells, ANC: absolute neutrophil count, 
ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, PT: prothrombin time, INR: international normalized ratio, aPTT: activated partial thromboplastin time, ATIII: 
antithrombin III.
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higher in the non-survivor group than in the survivor 
group. As admission DNI level increased, ICU scoring 
system values also increased. Additionally, the propor-
tion of survivors decreased. The DNI at PICU admission 
was also positively correlated with ICU scores, as well as 
lactate and CRP and negatively correlated with platelet 
counts. The optimal cut-off value obtained by ROC curve 
analysis for predicting survival was 4.95%, and mortal-
ity was significantly higher in patients with DNI ≥ 5.0% 
than in patients with DNI < 5.0%.
It is very challenging to identify patients with increased 
mortality risk early among critically ill children admitted 
to the PICU. The ideal marker of outcome in the PICU 
should be highly sensitive, specific, easily measurable, 
fast, and inexpensive and should correlate well with 
disease severity and prognosis. The DNI, which cor-
responds to the IG fraction in circulating blood, can be 
measured using an ADVIA-series automated cell ana-
lyzer. The DNI is an easily measurable parameter that 
is reported with the CBC count and a WBC differential. 
Thus, it has the advantage of no additional cost and being 
readily available. This study was performed to establish 
the clinical usefulness of the DNI by analyzing whether 
DNI predicts mortality and correlates with ICU scoring 
systems that reflect disease severity and other laboratory 
parameters in PICU patients.
 In a previous study conducted in adult subjects by 
Nahm et al.[12] DNI was helpful in evaluating the clini-
cal severity of patients with suspected sepsis and was 
significantly correlated with laboratory values of DIC; 
platelet count, PT, and  ATIII level. In another study by 
Park et al.[15] an increased DNI value at ICU admission 
was significantly associated with the presence of sepsis 
or septic shock and overt DIC and was positively cor-
related with DIC score but not WBC count and absolute 
neutrophil count in adult medical ICU patients clini-
cally suspected of sepsis at the time of ICU admission. 
Consequently, the authors suggested that an elevated 
DNI might reflect the disease severity of patients with 
sepsis and could be related to a hypercoagulable state as-
sociated with PT, activated partial thromboplastin time 
(aPTT), ATIII level, and platelet count. When analyzing 
all 516 participants, the DNI was also positively cor-
related with PT, aPTT, D-dimer level and platelet count. 
However, the ATIII level was not significantly different 
between survivors and non-survivors, although it was 
weakly correlated with DNI (r = –0.166, p < 0.015). This 
discrepancy may be due to differences in the study sub-
jects, as previous studies considered only adult patients 
with clinically suspected or diagnosed sepsis, whereas 
this study included a heterogeneous sample of pediatric 
Fig. 2. Survival curves for patients with delta neutrophil index 
(DNI) < 5.0% (solid line) and DNI ≥ 5.0% (dotted line). DN: delta 
neutrophil; PICU: pediatric intensive care unit.
Fig. 1. Receiver operating characteristic curve of delta neutrophil 
index for survival prediction (area under the curve: 0.748; 95% 
confidence interval: 0.687-0.808).
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patients and focused on mortality prediction.
In this study, the optimal cut-off value of DNI to pre-
dict mortality was 4.95%. In comparison, previous stud-
ies on circulating IG level, which is reflected by DNI, 
proposed a cut-off value of 3% for determining the pres-
ence of sepsis.[17,18] In a report by Park et al.[15] it was 
suggested that the optimal cut-off value  of DNI was 6.5% 
to predict sepsis or septic shock, and if the DNI increased 
by more than 4–6%, careful attention was required to 
detect possible concomitant DIC and/or sepsis or septic 
shock in patients with suspected sepsis. One reason that 
accounts for the difference between the cut-off value  in 
previous studies and ours is that the presence of severe 
sepsis/septic shock was the primary outcome in previous 
studies, whereas survival status was our primary out-
come.
There are some limitations in the current study. First, 
this study was a retrospective review of medical records. 
Large-scale prospective studies will be helpful in eluci-
dating the role of DNI in reflecting disease severity and 
predicting mortality. Second, because this study was 
conducted in a single medical PICU, our conclusions are 
limited to medical PICU patients and cannot be applied 
to all ICU patients including surgical problem. Lastly, 
Further study should include that usefulness and mean-
ing of DNI in subgroup not belong to sepsis or infection. 
However, this study is the first study to demonstrate that 
the DNI can be used as a prognostic marker in a hetero-
geneous population of critically ill pediatric patients and 
even in the immunocompromised patients in PICU, un-
like previous studies that considered only patients with 
suspected or diagnosed sepsis. Therefore, we suggest that 
DNI be considered a new indicator for predicting mortal-
ity in PICU patients.
In conclusion, DNI is associated with disease sever-
ity and mortality rate, and has the potential to serve as a 
prognostic marker in PICU patients. Accordingly, deter-
mining the DNI level at ICU admission can be helpful in 
deciding whether additional and more invasive diagnos-
tic procedures are required or whether therapeutic inter-
ventions should be modified. Measurement of the DNI 
in PICU patients may add significant information to that 
provided by markers and scoring systems already in use 
for assessing disease severity and predicting mortality.
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